Onzeald

Country: European Union

Language: Maltese

Source: EMA (European Medicines Agency)

Active ingredient:

etirinotecan pegol

Available from:

Nektar Therapeutics UK Limited

ATC code:

L01

INN (International Name):

etirinotecan pegol

Therapeutic group:

Aġenti antineoplastiċi

Therapeutic area:

Neoplażmi tas-Sider

Therapeutic indications:

It-trattament tal-kanċer tas-sider b'metastasi fil-moħħ.

Authorization status:

Miċħuda

Documents in other languages

Public Assessment Report Public Assessment Report Bulgarian 10-11-2017
Public Assessment Report Public Assessment Report Spanish 10-11-2017
Public Assessment Report Public Assessment Report Czech 10-11-2017
Public Assessment Report Public Assessment Report Danish 10-11-2017
Public Assessment Report Public Assessment Report German 10-11-2017
Public Assessment Report Public Assessment Report Estonian 10-11-2017
Public Assessment Report Public Assessment Report Greek 10-11-2017
Public Assessment Report Public Assessment Report English 10-11-2017
Public Assessment Report Public Assessment Report French 10-11-2017
Public Assessment Report Public Assessment Report Italian 10-11-2017
Public Assessment Report Public Assessment Report Latvian 10-11-2017
Public Assessment Report Public Assessment Report Lithuanian 10-11-2017
Public Assessment Report Public Assessment Report Hungarian 10-11-2017
Public Assessment Report Public Assessment Report Dutch 10-11-2017
Public Assessment Report Public Assessment Report Polish 10-11-2017
Public Assessment Report Public Assessment Report Slovenian 10-11-2017
Public Assessment Report Public Assessment Report Finnish 10-11-2017
Public Assessment Report Public Assessment Report Croatian 10-11-2017

Search alerts related to this product

View documents history